Address: | 4301 Emperor Blvd #200, Durham, NC 27703, USA |
---|---|
Postal code: | 27703 |
Phone: | (919) 973-1440 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Envisia Therapeutics, use the form below and your opinion, advice or comment will appear in this space.
Envisia Therapeutics, Research Triangle Park. Отметки "Нравится": 25. Official Facebook page of Envisia Therapeutics Inc. Подписаны 29 человек. ИнформацияВсе. 919-973-1440.
Envisia Therapeutics is a biotechnology company focused on the research and development of novel ocular therapies. Phone Number. (919)973-1440. As many as 285 million people suffer from disease-related visual impairments and blindness1, but an estimated 80 percent of these visual impairments...
Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. (919) 973-1440.
Envisia Therapeutics is a new company formed by Liquidia Technologies to develop novel therapeutics that can address critical unmet needs in ophthalmology. Private/Public: private Phone: (919) 973-1440 Fax: (919) 973-1441 Email: [email protected] Address: 4301 Emperor Blvd.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapi. Phone: 919-973-1440. Fax: 419 Davis Drive Suite 100 Morrisville, 27560 North Carolina, United States.
Envisia Therapeutics General Information. Description. Developer of a bio-research platform intended to focus on the development of novel ocular therapies. +1 (919) 000-0000. Want detailed data on 2M+ companies? What you see here scratches the surface.
Последние твиты от Envisia Therapeutics (@EnvisiaTx). Envisia Therapeutics is a privately held #biotech company leveraging its unique PRINT® technology to develop novel, sustained-release ocular therapies. Research Triangle Park, NC.
Envisia Therapeutics, Inc. Funding details. Envisia Therapeutics, Inc. Industry: Biotechnology CIK Number: 0001655970 Address: 419 DAVIS DRIVE SUITE 100 MORRISVILLE 27560 Phone number: 919.973.1440 Former name: Ascendia Therapeutics, Inc., date of change
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma.
Envisia's top competitors are Ocular, EyePoint Pharmaceuticals and Graybug Vision. Envisia's Competitors, Revenue, Number of Employees, Funding and Acquisitions. Envisia is engaged in the discovery and development of ocular therapeutics for the critical needs in ophthalmology.